TVM Capital

TVM Capital is a private equity and venture capital firm established in 1983 and headquartered in Munich, with offices across Europe, the United States, the Middle East and Asia. It provides early-stage through growth investments in life sciences, including biopharma, diagnostics, medtech, digital health, and in information and communications technology spanning software, semiconductors, telecommunications and related services. The firm typically invests between modest seven figures and low tens of millions of euros, often taking majority stakes in portfolio companies and supporting growth to market readiness, licensing, or global expansion. Exits are pursued through initial public offerings or sales to strategic buyers. The firm favors investments in Western markets, with attention to cross-border licenses and international collaboration.